These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19752362)

  • 1. Ranolazine as a cardioplegia additive improves recovery of diastolic function in isolated rat hearts.
    Hwang H; Arcidi JM; Hale SL; Simkhovich BZ; Belardinelli L; Dhalla AK; Shryock JC; Kloner RA
    Circulation; 2009 Sep; 120(11 Suppl):S16-21. PubMed ID: 19752362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranolazine as an adjunct to cardioplegia: a potential new therapeutic application.
    Hwang H; Arcidi JM; Hale SL; Simkhovich BZ; Belardinelli L; Dhalla AK; Shryock JC; Kloner RA
    J Cardiovasc Pharmacol Ther; 2009 Jun; 14(2):125-33. PubMed ID: 19329672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial role in ischemia-reperfusion of rat hearts exposed to high-K+ cardioplegia and clonazepam: energetic and contractile consequences.
    Consolini AE; Ragone MI; Conforti P; Volonté MG
    Can J Physiol Pharmacol; 2007 May; 85(5):483-96. PubMed ID: 17632582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
    Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
    J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
    Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
    J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cold cardioplegic arrest enhances heat shock protein 70 in the heat-shocked rat heart.
    Gray CC; Amrani M; Smolenski RT; Nakamura K; Yacoub MH
    J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1130-6. PubMed ID: 11385380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction.
    Wu Y; Song Y; Belardinelli L; Shryock JC
    J Pharmacol Exp Ther; 2009 Aug; 330(2):550-7. PubMed ID: 19403851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel.
    Hale SL; Leeka JA; Kloner RA
    J Pharmacol Exp Ther; 2006 Jul; 318(1):418-23. PubMed ID: 16617168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Na+/H+ exchanger inhibitor HOE-642 improves cardioplegic myocardial preservation under both normothermic and hypothermic conditions.
    Shipolini AR; Galiñanes M; Edmondson SJ; Hearse DJ; Avkiran M
    Circulation; 1997 Nov; 96(9 Suppl):II-266-73. PubMed ID: 9386109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.
    Fraser H; Belardinelli L; Wang L; Light PE; McVeigh JJ; Clanachan AS
    J Mol Cell Cardiol; 2006 Dec; 41(6):1031-8. PubMed ID: 17027025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-hydrogen exchange inhibition and beta-blockade additively decrease infarct size.
    Wang P; Zaragoza C; Holman W
    Ann Thorac Surg; 2007 Mar; 83(3):1121-7. PubMed ID: 17307470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antianginal agent ranolazine is a potent antiarrhythmic agent that reduces ventricular arrhythmias: through a mechanism favoring inhibition of late sodium channel.
    Kloner RA; Dow JS; Bhandari A
    Cardiovasc Ther; 2011 Aug; 29(4):e36-41. PubMed ID: 20626400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac-specific effects of parathyroid hormone-related peptide: modification by aging and hypertension.
    Ross G; Schlüter KD
    Cardiovasc Res; 2005 May; 66(2):334-44. PubMed ID: 15820202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranolazine antagonizes the effects of increased late sodium current on intracellular calcium cycling in rat isolated intact heart.
    Wasserstrom JA; Sharma R; O'Toole MJ; Zheng J; Kelly JE; Shryock J; Belardinelli L; Aistrup GL
    J Pharmacol Exp Ther; 2009 Nov; 331(2):382-91. PubMed ID: 19675298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dichotomy of ischemic preconditioning: improved postischemic contractile function despite intensification of ischemic contracture.
    Kolocassides KG; Galinanes M; Hearse DJ
    Circulation; 1996 May; 93(9):1725-33. PubMed ID: 8653879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Na+/H+ exchange inhibition in hypertrophied myocardium subjected to cardioplegic arrest: an effective cardioprotective approach.
    Kevelaitis E; Qureshi AA; Mouas C; Marotte F; Kevelaitiene S; Avkiran M; Menasché P
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):111-6. PubMed ID: 15621481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model.
    Leprán I; Pollesello P; Vajda S; Varró A; Papp JG
    J Cardiovasc Pharmacol; 2006 Oct; 48(4):148-52. PubMed ID: 17086092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioplegic strategies for calcium control: low Ca(2+), high Mg(2+), citrate, or Na(+)/H(+) exchange inhibitor HOE-642.
    Fukuhiro Y; Wowk M; Ou R; Rosenfeldt F; Pepe S
    Circulation; 2000 Nov; 102(19 Suppl 3):III319-25. PubMed ID: 11082408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.